Skip to main content
SpringerLink
Log in

Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Four subjects were synchronized with activity from 07 to 23 h and were given a single oral dose of 80 mg racemic propranolol at fixed times (08, 14, 20 and 02 h) at weekly intervals.

ANOVA revealed significant circadian changes in the peak propranolol concentration (Cmax), with a maximum at 08 h and a minimum at 02 h after drug intake; tmax was not dependent on the circadian phase. The elimination half-life varied significantly with the time of day, being shortest at 08 h (3.3 h) and longest at 20 h (4.9 h). The stereospecificity of the propranolol pharmacokinetics was not dependent on the time of drug intake. No circadian variation was found in the maximum decrease in heart rate, but the time to peak effect was dependent on the time of drug intake; tmax was 2.3 h at 08 h and 7.0 h at 02 h. Thus, the time to peak drug concentration did not coincide with the time to peak effect on heart rate at different times of day. Circadian changes were also found in the systolic blood pressure and in the double product.

The results show a significant daily variation in the pharmacokinetics and cardiovascular effects of propranolol. However, chronokinetics cannot explain the circadian changes in the effects of the drug. It is concluded that circadian variation in sympathetic tone and vascular reactivity is mainly responsible for the circadian changes in the effects of propranolol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Carrageta M, Soares R, Martins A (1983) Bewertung der blutdrucksenkenden Wirkung von einmal täglich verabreichten Beta-Blockern im tagesperiodischen Verlauf. In: Magometschnigg D, Hitzenberger G (eds) Blutdruckvariabilität. Uhlen, Wien, pp 118–125

    Google Scholar 

  2. Joy M, Pollard MC, Nunan TO (1982) Diurnal variation in exercise responses in angina pectoris. Br Heart J 48: 156–160

    Google Scholar 

  3. Mann S, Millar-Craig MW, Balasubramanian V, Raftery EB (1980) Propranolol LA and ambulatory blood pressure. Br J Clin Pharmacol 10: 443–447

    Google Scholar 

  4. Millar-Craig MW, Mann S, Balasubramanian V, Raftery EB (1978) Blood pressure circadian rhythm in essential hypertension. Clin Sci Mol Med 55: 391–393

    Google Scholar 

  5. Quyyumi AA, Wright C, Mockus L, Fox KM (1984) Effect of partial agonist activity in β-blockers in severe angina pectoris: A double-blind comparison of pindolol and atenolol. Br Med J 289: 951–953

    Google Scholar 

  6. Lemmer B (1986) The chronopharmacology of cardiovascular medications. Ann Rev Chronopharmacol 2: 199–228

    Google Scholar 

  7. Lemmer B, Bathe K (1982) Stereospecific and circadian-phase-dependent behavior of d,l-, l- and d-propanolol in plasma, heart and brain of light-dark-synchronized rats. J Cardiovasc Pharmacol 4: 635–644

    Google Scholar 

  8. Lemmer B, Bathe K, Lang PH, Neumann G, Winkler H (1983) Chronopharmacology of β-adrenoceptor blocking drugs: Pharmacokinetic and pharmacodynamic studies in rats. J Am Coll Toxicol 2: 347–358

    Google Scholar 

  9. Lemmer B, Winkler H, Ohm T, Fink M (1985) Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat. Naunyn-Schmiedebergs Arch Pharmacol 330: 42–49

    Google Scholar 

  10. Semenowicz-Siuda K, Markiewicz A, Korcynska-Wardecka J (1984) Circadian bioavailability and some effects of propranolol in healthy subjects and in liver cirrhosis. Int J Clin Pharmacol Ther Toxicol 22: 653–658

    Google Scholar 

  11. Winkler H, Ried W, Lemmer B (1982) High-performance liquid chromatographic method for the quantitative analysis of the aryloxypropanolamines propranolol, metoprolol and atenolol in plasma and tissues. J Chromatogr 228: 223–234

    Google Scholar 

  12. Gübitz G, Mihellyes S (1984) Optical resolution of β-blocking agents by thin-layer chromatography and high-performance liquid chromatography as diastereomeric R-(−)-l-(l-naphthyl)-ethyl-ureas. J Chromatogr 314: 462–466

    Google Scholar 

  13. Thompson JA, Holtzman JL, Tsuru M, Leman CL (1982) Procedure for the chiral derivatization and chromatographic resolution of R-(+)- and S-(−)-propranolol. J Chromatogr 238: 470–475

    Google Scholar 

  14. Wilson MJ, Walle T (1984) Silica gel high-performance liquid chromatography for the simultaneous determination of propranolol and 4-hydroxypropranolol enantiomers after chiral derivatization. J Chromatogr 310: 424–430

    Google Scholar 

  15. Vokac M (1984) A comprehensive system of cosinor treatment programs written for the Apple II microcomputer. Chronobiol Int 1: 87–92

    Google Scholar 

  16. Lemmer B (1984) Chronopharmakologie — Tagesrhythmen and Arzneimittelwirkung, 2nd edn. Wiss Verlagsges, Stuttgart

    Google Scholar 

  17. Lemmer B, Labrecque G (1987) Chronopharmacology and chronotherapeutics: Definitions and concepts. Chronobiol Int 4: 319–329

    Google Scholar 

  18. Reinberg A, Smolensky MH (1983) (eds) Biological rhythms and medicine. Springer-Verlag, Berlin Heidelberg New York Tokyo

    Google Scholar 

  19. Hermansson J, von Bahr C (1980) Simultaneous determination of d- and l-propranolol in human plasma by high-performance liquid chromatography. J Chromatogr 221: 109–117

    Google Scholar 

  20. Olanoff LS, Walle T, Walle K, Cowart TD, Gaffney TE (1984) Stereoselective clearance and distribution of intravenous propranolol. Clin Pharmacol Ther 35: 755–761

    Google Scholar 

  21. Silber B, Holford NHG, Riegelmann S (1982) Stereoselective disposition and glucuronidation of propranolol in humans. J Pharm Sci 71: 699–704

    Google Scholar 

  22. Wainer IW, Doyle TD, Donn KH, Powell JR (1984) The direct enantiomeric determination of (−)- and (+)-propranolol in human serum by high-performance liquid chromatography on a chiral stationary phase. J Chromatogr 306: 405–411

    Google Scholar 

  23. Walle T, Walle KU, Wilson MJ, Fagan TC, Gaffney TE (1984) Stereoselective ring oxidation of propranolol in man. Br J Clin Pharmacol 18: 741–747

    Google Scholar 

  24. McLean AF, Isbister C, Bobok A, Dudley FJ (1981) Reduction of first pass hepatic clearance of propranolol by food. Clin Pharmacol Ther 30: 31–43

    Google Scholar 

  25. Walle T, Fagan TC, Walle UK, Oexmann M-J, Conradi EC, Gaffney TE (1981) Food-induced increase in propranolol bioavailability-relationship to protein and effects on metabolites. Clin Pharmacol Ther 30: 790–795

    Google Scholar 

  26. Mullen PE, Lightman S, Linsell C, McKeon P, Sever PS, Todd K (1981) Rhythm of plasma noradrenaline in man. Psychoendocrinology 6: 213–222

    Google Scholar 

  27. Mikuni M, Saito Y, Koyama T, Daiguji M, Yamashita I, Yamazaki K, Honma M, Ui M (1978) Circadian variations in plasma 3′:5′-cyclic adenosine monophosphate and 3′: 5′-cyclic guanosine monophosphate of normal adults. Life Sci 22: 667–672

    Google Scholar 

  28. Lemmer B, Saller R (1974) Influence of light and darkness on the turnover of noradrenaline in the rat heart. Naunyn-Schmiedebergs Arch Pharmacol 282: 75–84

    Google Scholar 

  29. Lang P-H, Bissinger H, Lemmer B (1985) Circadian ryhthm and seasonal variations in basal cAMP content of rat heart ventricles. Chronobiol Int 2: 41–45

    Google Scholar 

  30. Hossmann V, Fitzgerald GA, Dollery CT (1980) Circadian rhythm of baroreflex reactivity and adrenergic vascular response. Cardiovasc Res 14: 125–129

    Google Scholar 

  31. Lemmer B, Langner B (1985) Daily variations in pharmacokinetics and cardiovascular effects of oral propranolol in man. Naunyn-Schmiedebergs Arch Pharmacol 329: R60

Download references

Author information

Authors and Affiliations

  1. Center of Pharmacology, J. W. Goethe-University, Frankfurt/Main, Federal Republic of Germany

    B. Langner & B. Lemmer

Authors
  1. B. Langner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Lemmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Langner, B., Lemmer, B. Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. Eur J Clin Pharmacol 33, 619–624 (1988). https://doi.org/10.1007/BF00542498

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00542498

Key words

Search

Navigation